Onytec (Ciclopirox)

Ciclopirox chelates essential metal ions, inhibiting metal‑dependent enzymes required for fungal cell metabolism. This disrupts membrane transport, respiration, and DNA synthesis, leading to fungal cell death while sparing human cells, providing an effective topical antifungal action.

The dosage of Onytec is determined by the prescribing healthcare professional based on the infection type, location, and patient characteristics. The prescriber will specify the amount to apply, frequency, and duration of treatment on the product label or prescription.

Safety data for ciclopirox in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any unknown risks before prescribing Onytec to pregnant or nursing individuals. Consultation with a physician is recommended.

To order Onytec, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Onytec (ciclopirox) belongs to the hydroxypyridone class, offering a broad spectrum against dermatophytes and yeasts. Unlike azole or allylamine agents, ciclopirox works by metal chelation rather than inhibiting ergosterol synthesis, which can be advantageous in resistant strains and may result in a different side‑effect profile.

Onytec should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and ensure it is out of reach of children.

Apply a thin layer of Onytec to clean, dry skin or nail surfaces as directed by the prescriber. Typically, the product is rubbed gently into the affected area once or twice daily, avoiding contact with eyes and mucous membranes unless instructed otherwise.

Serious risks, though rare, include allergic contact dermatitis, severe skin reactions such as blistering or swelling, and systemic hypersensitivity. Patients should discontinue use and seek medical attention if they experience any signs of a serious allergic reaction.

Onytec should not be used on severely damaged, ulcerated or inflamed skin, nor on patients with known hypersensitivity to ciclopirox or any excipients in the formulation. Individuals with uncontrolled systemic fungal infections should seek alternative systemic therapy.